인쇄하기
취소

KFDA streamlines license-related regulations

Published: 2004-05-25 06:58:00
Updated: 2004-05-25 06:58:00
The Korea Food and Drug Administration said recently that it has streamlined a guideline relating to license or report of drugs and this was already notified to each KFDA regional agency.

The guideline covers changes in a manufacturer of bioequivalence items, toll manufacturing of pleural manufacturers, serial brandnames, and items listed in the Korea Pharmacopoeia, and salient points of whi...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.